Bile acid sequestrant reduces glucose concentration in T2DM
(HealthDay)—For patients with type 2 diabetes taking metformin monotherapy, the bile acid sequestrant colesevelam reduces fasting and postprandial glucose concentrations without any effects on insulin concentration, secretion, ...
Jan 30, 2013
0
0